FiercePharmaOriginal article
{"a":[{"_":"Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring","$":{"href":"/pharma/narcan-maker-emergent-biosolutions-eliminates-top-rd-role-sweeping-restructuring","hreflang":"en"}}]}
NarcanNegative
AI Analysis
Summary
Emergent BioSolutions CEO Joseph Papa announced a restructuring that includes elimination of a top R&D role as part of efforts to align the business with current realities. The move represents another round of organizational changes under Papa's leadership.
Outcome Details
Restructuring involving elimination of top R&D role
Importance:3/10
Sentiment:
-0.60
restructuringR&Dmanagement changescost reduction
Related Companies
Read the original article
Published by FiercePharma on August 5, 2026 6:13 PM